NIH State-of-the-Science Conference Statement
Cesarean Delivery on Maternal Request
27–29 March 2006
|
NIH consensus and state-of-the-science statements are
prepared by independent panels of health professionals and public
representatives on the basis of (1) the results of a systematic
literature review prepared under contract with the Agency for
Healthcare Research and Quality (AHRQ), (2) presentations by
investigators working in areas relevant to the conference questions
during a 2-day public session, (3) questions and statements from
conference attendees during open discussion periods that are part of
the public session, and (4) closed deliberations by the panel during
the remainder of the second day and morning of the third. This
statement is an independent report of the panel and is not a policy
statement of the NIH or the Federal Government.
The statement
reflects the panel's assessment of medical knowledge available at
the time the statement was written. Thus, it provides a
"snapshot in time" of the state of knowledge on the
conference topic. When reading the statement, keep in mind that new
knowledge is inevitably accumulating through medical research, and
that the information provided is not a substitute for professional
medical care or advice. |
Introduction
Since the late 1970s, the U.S. cesarean delivery rate has received
considerable attention. Primary and repeat cesarean delivery rates for all
women have now reached their highest levels. Cesarean delivery on maternal
request is defined as a cesarean delivery for a singleton pregnancy on
maternal request at term in the absence of any medical or obstetric
indications. Cesarean delivery on maternal request is a subset of elective
cesarean delivery. Elective cesarean delivery includes a planned cesarean
delivery for a wide range of maternal and fetal indications and is
generally distinguished from emergency cesarean delivery and “labored”
cesarean delivery after planned vaginal delivery. In 2004, 1.2 million or
29.1 percent of live births in the United States were by cesarean
delivery. Internationally and domestically, estimates of cesarean delivery
on maternal request range from 4 to 18% of all cesarean deliveries;
however, there is little confidence in the validity of this estimate.
Limited evidence suggests that cesarean delivery on maternal request is
increasing, but it is unclear why. Cesarean delivery on maternal request
should be guided by the best possible information regarding potential
health outcomes for both mother and baby. Toward that end, the National
Institute of Child Health and Human Development (NICHD) and the Office of
Medical Applications of Research (OMAR) of the National Institutes of
Health (NIH) convened a State-of-the-Science Conference from March 27 to
29, 2006, to assess the available scientific evidence relevant to the
following questions:
- What is the trend and incidence of cesarean delivery over time in
the United States and other countries (when possible, separate by
intent)?
- What are the short-term (under 1 year) and long-term benefits and
harms to mother and baby associated with cesarean delivery by request
versus attempted vaginal delivery?
- What factors influence benefits and harms?
- What future research directions need to be considered to get
evidence for making appropriate decisions regarding cesarean delivery on
request or attempted vaginal delivery?
An impartial, independent panel was charged with reviewing the
available published literature in advance of the conference, including a
systematic literature review commissioned through the Agency for
Healthcare Research and Quality (AHRQ). The first day and a half of the
conference consisted of presentations by expert researchers and
practitioners as well as open public discussions. The panel held a press
conference to address questions from the media. The draft statement was
published online.
Back
to Top
1. What are the trends and incidence of cesarean delivery over time in
the United States and other countries (when possible, separate by
intent)?
After rapid increases in the 1970s and early 1980s, total cesarean
delivery rates in the United States declined in the late 1980s through to
1996, after which they again increased. In 2004, the rate of cesarean
delivery was 29.1%, the highest ever reported. One of the major drivers of
the overall increase in cesarean delivery has been that, after a first
cesarean delivery, the likelihood of cesarean delivery increases in
subsequent pregnancies. The increase in primary cesarean delivery
parallels the total cesarean delivery rate, which cannot, therefore, be
explained by the decreasing use of vaginal birth after cesarean (VBAC)
(Figure 1).
Figure 1. Total and primary cesarean rate and vaginal birth
after previous cesarean (VBAC): United States, 1989–2004, Centers for
Disease Control
†Preliminary
data 1Number of vaginal births after previous cesarean per
100 live births to women with a previous cesarean
delivery. 2Percentage of all live births by cesarean
delivery. 3Number of primary cesarean deliveries per 100
live births to women who have not had a previous cesarean. NOTE: Due
to changes in data collection from implementation of the 2003 revision
of the U.S. Standard Certificates of Live Birth, there may be small
discontinuities in rates of primary cesarean delivery and VBAC in 2003
and 2004.
Primary cesarean delivery is increasing in all ethnic and age groups.
In the absence of any increase in known clinical risk factors for primary
cesarean delivery, it is plausible that some of the primary cesarean
delivery increase is because of cesarean delivery on maternal request.
However, cesarean delivery on maternal request is not readily identifiable
in any existing studies or U.S. national databases, either currently or
historically. It has been estimated, in the United States and
internationally, that approximately 4–18% of all cesarean deliveries are
on maternal request, but there is little confidence in the validity of
these estimates. One published study of primary cesarean delivery with “no
indicated risk,” using national U.S. birth certificate data from 1991 to
2001, showed overall increases from 3.3% to 5.5% of all live births, with
higher rates in older primiparous women (increases in primiparous women
age 40 and older from 18.2% to 25.7%). However, birth certificates do not
indicate “maternal request,” so these reports cannot be used to
confidently infer cesarean delivery on maternal request. It is also
suggested, using statistical algorithms to identify women requesting
cesarean delivery, that cesarean delivery without labor or some medical
indication has increased from 1.9% of all deliveries in 2001 to 2.6% in
2003, but this too requires confirmation.
Other countries report cesarean delivery rates increasing over recent
time but generally at lower levels than found in the United States. For
example, in Canada, the overall cesarean delivery rate increased from
18.0% in 1994–1995 to 22.1% in 2000–2001. Similarly, most countries do not
collect information specifically about patient choice, and information
that is reported comes from special surveys. One hospital in Italy
reported that maternal request rose from 4.5% of all cesarean deliveries
in 1996 to 9% in 2000. A Swedish hospital reported increases from 8.9% in
1994 to 15.8% in 1999, and in Norway, in 1998–1999, a national survey
found 7.6% of all cesarean deliveries performed were by maternal request.
Taiwan has a national database that codes for cesarean deliveries
performed at maternal request. The rate of deliveries so coded increased
from 2% (of all women without a clinical indication for cesarean delivery)
in 1997 to 3.5% in 2001, with higher increases in women 35 and older
(respectively, 3.6% increased to 6.6%). Because in Taiwan cesarean
delivery on maternal request is only reimbursed at the cost of vaginal
deliveries, these rates may be spuriously low.
Some authors have proposed an “ideal rate” of all cesarean deliveries
(such as 15%) for a population. There is no consistency in this ideal
rate, and artificial declarations of an ideal rate should be discouraged.
Goals for achieving an optimal cesarean delivery rate should be based on
maximizing the best possible maternal and neonatal outcomes, taking into
account available medical and health resources and maternal preferences.
Thus, optimal cesarean delivery rates will vary over time and across
different populations according to individual and societal
circumstances.
Indications for cesarean delivery represent a continuum ranging from
clear medical need, such as placenta previa, to women with no risk factors
who declare a preference for cesarean delivery well before labor. Many
women have multiple indications for cesarean delivery in the same
pregnancy. This makes it problematic in many cases to determine whether or
not a specific cesarean delivery is due to maternal request. Hence, the
collection of precise statistics on prevalence of cesarean delivery by
indication is difficult.
Back
to Top
2. What are the short-term (less than 1 year) and long-term benefits
and harms to mother and baby associated with cesarean delivery by request
versus attempted vaginal delivery?
Framework of the Evidence Analysis
The plan for the evidence review was to assess the state of the science
regarding outcome differences in women who elect planned cesarean delivery
versus planned vaginal delivery. The planned cesarean delivery group is
assumed to consist of women who elect cesarean delivery by 39–40 weeks of
gestation including those who had experienced onset of spontaneous labor
prior to their scheduled cesarean delivery dates. The planned vaginal
delivery group is heterogeneous because it consists of women electing
vaginal delivery who will have spontaneous or assisted vaginal delivery or
indicated cesarean delivery after labor or spontaneous rupture of
membranes up to 42 weeks of gestation.
Good quality evidence directly assessing differences in outcomes
between planned cesarean delivery and planned vaginal delivery is sparse;
thus, the analysis frequently relies on proxy definitions such as
“scheduled cesarean” for “planned cesarean” and “vaginal births plus
emergency cesareans” for “planned vaginal delivery.” A number of potential
outcomes were not assessed due to a lack of data availability or clarity.
Among these were hospital readmissions, adhesions, and chronic abdominal
and pelvic pain syndrome.
The panel considered data summarized in the Evidence-based Practice
Center (EPC) Report, additional evidence identified separately from cohort
and case-control studies, and input from the invited speakers and audience
participants at the NIH State-of-the-Science Conference.
Quality and Relevance of the Evidence
For the evidence obtained from the EPC report, the panel utilized an
evidence quality grading scale provided within the document: Level
I—strong, Level II—moderate, Level III—weak, and Level IV—absent. No Level
I evidence was found, three outcomes had Level II evidence, and the
remaining outcomes were Level III or IV. Interpretation of many outcome
variables was confounded by a lack of appropriate comparison groups, a
lack of consistency in outcome definitions, and the frequent use of
composite outcomes.
Maternal Outcomes with Moderate-Quality Evidence
Two outcome variables had moderate-quality evidence. Both were
short-term maternal variables.
Hemorrhage. The frequency of postpartum hemorrhage
associated with planned cesarean delivery is less than that reported with
the combination of planned vaginal delivery and unplanned cesarean
delivery.
Maternal length of hospital stay. Cesarean delivery,
planned or otherwise, requires a longer hospital stay than vaginal
delivery does. However, these analyses are affected by comparing planned
and unplanned cesarean deliveries to all vaginal deliveries. Numerous
factors may also influence length of hospital stay, including obstetric
complications, insurance coverage, regional practice patterns, health care
provider and patient preference, and neonatal hospital stay.
Back
to Top
Maternal Outcomes with Weak-Quality Evidence Which Favor Planned
Vaginal Delivery
Infection. The rate of infection is lower for all
vaginal deliveries than for all cesarean deliveries. Planned cesarean
deliveries have lower infection rates than unplanned cesarean deliveries
but higher rates than vaginal deliveries.
Anesthetic complications. Conflicting studies
generally show a lower rate of anesthetic complications with planned
vaginal delivery than with planned cesarean delivery. However, the
surveyed literature has a higher prevalence of general anesthesia and a
decreased utilization of regional anesthesia for unscheduled cesarean
deliveries than in contemporary practice, which may mitigate the possible
advantage for planned vaginal delivery. A potential advantage of planned
cesarean delivery is the avoidance of emergency induction of anesthesia.
While in-hospital post-cesarean analgesia practices have improved
markedly, less attention has been focused on quantitation and management
of perineal pain. Reliable information is lacking regarding short term
post-discharge pain.
Subsequent placenta previa. The risk of this
complication increases with the number of prior cesarean deliveries,
advancing maternal age, and parity. A meta-analysis indicates a doubling
of risk in women who have had cesarean deliveries compared to women who
have had vaginal deliveries.
Breastfeeding. Early and sustained breastfeeding is an
important practice promoting infant and child health. A meta-analysis
found that women who had cesarean delivery (planned and unplanned
combined) were more likely to bottle feed than women who had vaginal
deliveries. However, social practices and medical factors (early bonding
or infant isolation from mother who had cesarean delivery, medical
complications, neonatal intensive care unit [NICU] admissions and
specifics of surgical recovery) may delay the initiation of breastfeeding.
Limited data from randomized controlled trials indicate no difference in
the duration of breastfeeding when planned cesarean delivery and vaginal
deliveries were compared within the first year.
Maternal Outcomes with Weak-Quality Evidence That Favor Cesarean
Delivery on Maternal Request
Urinary incontinence. Studies indicate that the rate
of stress urinary incontinence (SUI) after elective cesarean delivery is
lower than for vaginal delivery, but the duration of this effect is not
clear, particularly in older populations and in women who had multiple
deliveries. There is evidence that the risk of SUI may be increased when
forceps are used to assist vaginal delivery. Urinary incontinence is
multifactorial, and reduction in SUI associated with cesarean delivery on
maternal request may be partially offset by other processes including
advancing age and increases in body-mass index (BMI).
Surgical and traumatic complications. The evidence
consistently indicates a lower risk of surgical complications in elective
cesarean than in unplanned cesarean delivery resulting from attempted
vaginal delivery. Among planned vaginal delivery, which includes assisted
deliveries and in-labor cesareans, there is a significantly higher rate of
obstetric trauma than among planned cesarean delivery. The net direction
of the evidence thus favors planned cesarean delivery. However, the
frequency of obstetric trauma, such as third and fourth degree perineal
lacerations, can be reduced by labor management practices such as reducing
the use of midline episiotomy and limiting the use of forceps delivery
whenever possible.
Back
to Top
Maternal Outcomes With Weak-Quality Evidence That Are Sensitive to
Parity and Planned Family Size
Subsequent uterine rupture. Uterine rupture is a
concern in subsequent pregnancies. Meta-analyses provide consistent
evidence that the incidence of uterine rupture during attempted VBAC is
significantly higher than with elective repeat cesarean delivery.
Hysterectomy. Existing evidence from weak-quality
studies has shown no difference in the risk of peripartal hysterectomy
among those with first planned vaginal delivery or planned cesarean
delivery, although these studies generally lacked adequate power to
examine these outcomes. However, there is convincing evidence of increased
risk of hemorrhage and hysterectomy in patients with multiple cesarean
deliveries; decisions regarding route of delivery should be influenced by
the number of pregnancies expected or planned. The risk of hysterectomy
for placenta previa and placenta accreta increases sharply with increasing
numbers of cesarean deliveries. For the women with one prior cesarean
delivery, a decision-analysis indicated that cesarean delivery likely will
result in fewer hysterectomies because of the decreased incidence of
uterine rupture. However, in women with multiple cesarean deliveries, the
likelihood of hysterectomy is elevated because of the increased frequency
of placenta accreta.
Subsequent fertility. Cohort studies have demonstrated
a reduction in subsequent pregnancies in women with cesarean delivery
compared to those who delivered vaginally. This effect may be due to
voluntary limitation of family size.
Maternal Outcomes with Weak-Quality Evidence That Favor Neither
Delivery Route
Inconsistent assessments and variable definitions prevented judgment
regarding risks by delivery route for the following outcomes: anorectal
function, postpartum pain, postpartum depression, sexual function, pelvic
pain, and fistula. For thromboembolism, there was conflicting evidence.
The following outcomes warrant further discussion.
Anorectal function. Several case-control studies
supply weak-quality evidence for reduced risk of anal incontinence in
planned cesarean delivery compared with unplanned cesarean deliveries or
instrumental vaginal deliveries. The data demonstrate an association
between anal sphincter disruption and fecal incontinence. Use of midline
episiotomy and use of forceps are associated with sphincter disruption.
Limiting these practices can reduce the frequency of this injury.
Sexual function. Any differences in sexual function
based on route of delivery were no longer evident by 6 months postpartum.
Factors that affect sexual functioning, such as changing family roles,
relationship satisfaction, physical recovery or continuing morbidities,
mood, and lack of sleep, have not been adequately studied.
Pelvic organ prolapse. While evidence regarding
different modes of delivery is weak, reliable data indicate an association
between pelvic organ prolapse and parturition: relative risk increasing
with parity. Other data suggest an association between some vaginal
deliveries and levator muscle, connective tissue, and pelvic nerve injury
that may be the cause of pelvic organ prolapse or stress incontinence.
However the precise relationship with these conditions, as well as
possible modifiers of labor management to avoid such injuries, remains to
be delineated.
Subsequent stillbirth. There were inadequate data to
judge a difference between delivery routes for this outcome. Although a
recent retrospective cohort study suggested higher stillbirth risk in
subsequent pregnancies in women who had a previous cesarean delivery, the
lack of documentation of the indication for the prior cesarean delivery
limits interpretation of this outcome.
Maternal mortality. Existing studies were inadequately
powered to evaluate maternal morbidity.
Back
to Top
Neonatal Outcome with Moderate-Quality Evidence That Favors Planned
Vaginal Delivery
Respiratory morbidity. Evidence indicates that
respiratory morbidity, which is sensitive to gestational age, is higher
for cesarean deliveries than for vaginal deliveries. Studies consistently
report increasing respiratory morbidity with elective cesarean delivery
compared to planned vaginal delivery with gestational ages earlier than
39–40 weeks of gestation. Most of the respiratory problems that accompany
cesarean delivery result from delays in neonatal transition, such as
transient tachypnea of the newborn and mild respiratory distress syndrome
(RDS). Infrequently, infants can develop severe respiratory failure and
pulmonary hypertension.
Neonatal Outcomes with Weak-Quality Evidence That Favor Planned
Vaginal Delivery
Iatrogenic prematurity. No studies directly addressed
unexpected prematurity and allowed comparisons by type of cesarean
delivery with intended or actual vaginal delivery. However, there is an
approximate doubling of the rates of respiratory symptoms and other
problems of neonatal adaptation (e.g., hypothermia, hypoglycemia) and NICU
admissions for infants delivered by cesarean delivery for each week below
39–40 weeks of gestation. Therefore, cesarean delivery on maternal request
may be associated with a number of neonatal morbidities. These effects can
be minimized if gestational age is accurately known, lung maturity is
documented, and elective cesarean delivery is not performed before 39
weeks of gestation.
Neonatal length of hospital stay. Evidence indicates
that neonatal length of hospital stay is longer for elective cesarean
delivery than for vaginal delivery. Length of stay may be increased when
delivery is complicated.
Neonatal Outcomes with Weak-Quality Evidence That Favor Cesarean
Delivery on Maternal Request
Fetal mortality. Based on epidemiologic modeling,
there is an increased risk of stillbirth in the planned vaginal delivery
group, because planned cesarean delivery would result in delivery by 40
weeks of gestation, and planned vaginal delivery could occur up to 42
weeks of gestation.
Intracranial hemorrhage, neonatal asphyxia, and
encephalopathy. Consistently higher rates of intracranial
hemorrhage are observed in operative vaginal delivery and cesarean
delivery in labor, suggesting cesarean delivery on maternal request should
be associated with lower risk of intracranial hemorrhage than the
aggregate of spontaneous and assisted vaginal deliveries that comprise
planned vaginal delivery. Evidence indicates a lower risk of neonatal
asphyxia and encephalopathy with elective cesarean delivery compared to
operative and spontaneous vaginal deliveries plus emergency or labored
cesareans, which comprise planned vaginal delivery.
Birth injury and laceration. The incidence of brachial
plexus injury is significantly lower in cesarean delivery than in
spontaneous vaginal delivery and significantly lower than in assisted
vaginal delivery. There is an increased rate of fetal lacerations among
emergency and labored cesarean deliveries than among elective cesarean
delivery, suggesting that cesarean delivery on maternal request poses no
additional risk for fetal lacerations beyond those associated with planned
vaginal delivery.
Neonatal infection. Infants born by planned vaginal
delivery have more evaluations for infection than do infants delivered by
planned cesarean delivery. The incidence is also increased.
Neonatal Outcome That Favors Neither Planned Delivery Route
Studies of neonatal mortality lacked statistical power. Poor data
quality limited interpretation of studies on long-term neonatal
outcomes.
Summary
With the exception of three outcome variables with moderate-quality
evidence (maternal hemorrhage, maternal length of stay, and neonatal
respiratory morbidity), all remaining outcome assessments considered by
the panel were based on weak evidence. This significantly limits the
reliability of judgments regarding whether an outcome measure favors
either cesarean delivery on maternal request or planned vaginal
delivery.
Back
to Top
3. What factors influence benefits and harms?
For most women, vaginal birth is the norm. Indications for cesarean
delivery vary widely and present as a spectrum. Fear of labor and its
potential complications as well as desire for control stand at one end of
the spectrum and may be influenced by a woman’s personal experiences. At
the other end of the spectrum are absolute medical indications, such as
placenta previa. It may be difficult to identify the precise point along
this continuum at which the request for cesarean delivery is not medically
indicated. Although the potential benefits and harms favor neither planned
vaginal delivery nor cesarean delivery on maternal request, there are
patient-specific, cultural, and societal factors; health care provider
issues; professional resources; and ethical issues that could influence
the benefits and harms of cesarean delivery on maternal request.
Patient-Specific Factors
Age is an important and independent risk factor for cesarean delivery.
As women age, subfertility is more common, as is the use of reproductive
technologies to achieve pregnancy. Complications in labor may be
associated with increasing maternal age and with the use of reproductive
technologies. Given that an increasing number of women are choosing to
delay having their first child, the relative benefits of cesarean delivery
on maternal request may outweigh the risks.
Childbearing plans influence harms and benefits of cesarean delivery on
maternal request. Morbidity and serious complications increase
substantially in women with increasing numbers of pregnancies. Therefore,
planned vaginal delivery provides an improved benefit/risk ratio for women
who desire several children.
Obesity is a known risk factor for cesarean delivery and for
postoperative surgical morbidity such as infectious complications and
venous thromboembolism. Obesity is also a risk factor for urinary
incontinence and pelvic floor disorders. Additionally, obesity
significantly increases the risks associated with an emergent cesarean
delivery during labor. Current evidence does not provide a clear estimate
of the risks and benefits of cesarean delivery on maternal request in
obese women.
Accuracy of estimated gestational age and the calculated estimated date
of confinement (due date) can substantially affect the risk/benefit ratio
of cesarean delivery on maternal request because neonatal respiratory
morbidity decreases with increasing gestational age. Uncertainty regarding
gestational dating is not uncommon and can lead to estimated dates that
are inaccurate by 2 or 3 weeks. Elective cesarean delivery at presumed 39
weeks of gestation has the potential to result in neonatal respiratory
morbidity. Therefore, adherence to established guidelines to increase the
accuracy of gestational age is imperative when making the decision to
provide cesarean delivery on maternal request.
Psychological factors may influence maternal decisions regarding mode
of delivery. Personality factors, such as a need to be in control of the
birth process, may be paramount for some women. Life-altering experiences,
such as interpersonal violence, traumatic delivery, or infant death, can
lead to symptoms of posttraumatic stress disorder, depression, or feelings
of guilt that influence a woman’s decision. Such experiences or illnesses
can cause ambivalence regarding the pregnancy, or even an overwhelming
fear of labor and delivery. Satisfaction with birth and quality of
postpartum life are important outcomes of the delivery process, few data
are available to facilitate an understanding of these factors. Anxiety
about delivery and feelings of inadequacy regarding labor can complicate
the decisionmaking process. Given the potential of such potent
psychological factors, the line between what constitutes an acceptable
“medical indication” and what is not medically indicated becomes less
clear.
Cultural and Societal Issues
Cultural beliefs and practices influence perceptions and desires
regarding labor and delivery. Some cultures have developed rituals and
customs associated with vaginal birth. Active participation in the process
of labor and birth are important experiences with significant
psychological benefits. Other women may attribute less importance to the
specifics of delivery and value the control of the process afforded by
cesarean delivery as a benefit. In any discussion of the relative benefits
and risks of cesarean delivery on maternal request versus planned vaginal
delivery, the cultural and personal importance of labor and delivery
should be valued.
A consequence of the increasing rates of cesarean delivery is that this
mode of delivery may be perceived as the norm. The perception that the
risks of cesarean delivery are similar or lower than attempted VBAC and
the shift away from vaginal breech deliveries may further contribute to
societal acceptance of cesarean births. Media coverage may further
increase concerns about the potential morbidity of planned vaginal
delivery. Such a shift in acceptance by patients and providers may lead to
an increase in cesarean delivery on maternal request.
Health Care Provider Type and Professional Resources
Obstetric health care providers in the United States include midwives,
family practice physicians, obstetricians, and maternal–fetal medicine
specialists. Factors that influence health care provider attitude
contribute to the complexity of the issues surrounding cesarean delivery
on maternal request. A health care provider’s view of cesarean delivery on
maternal request may be influenced by his or her training, practice
environment and experience, personal philosophy regarding birth, and
medical-legal experiences.
Most births in the United States are managed in a hospital setting. The
geographical location and the level of perinatal services in the hospital
may be a consideration, especially in the management of a birth that may
result in cesarean delivery. A woman may make a decision regarding
delivery site based on the level of care or technology she perceives
necessary or desirable. Such consideration may include the availability of
anesthesiologists or operating room staff for cesarean delivery, and may
extend to the issue of time of day that such services are available. The
availability of resources also may influence a provider’s recommendation
regarding cesarean delivery. Hospital resources such as operating rooms
and staff may be factors that influence the decision to schedule a
cesarean delivery. The unpredictability of the timing and length of labor
for a health care provider’s lifestyle and fatigue level presents
challenges to patient safety. Economic considerations, such as insurance
coverage, payment, and scheduling conflicts, may also impact a health care
provider’s decision to perform an elective cesarean delivery. Because of
the complexity of these situations and the potential for biased
recommendations, women should be fully informed about these issues and
actively participate in the decisionmaking process.
Ethical Issues
The foundation of the ethical relationship between a woman and her
healthcare providers is based on a respectful partnership that requires
the exchange of accurate information and effective communication. In the
context of childbirth, this process includes discussions of the relative
risks and benefits of planned vaginal delivery, including a realistic
assessment of the potential complications and outcomes. If a woman
requests information on cesarean delivery in the absence of medical
indication, her health care provider should engage in nondirective
counseling that incorporates the woman’s values and cultural context with
sensitivity to the patient’s concerns. For example, if the woman has a
fear of the pain during labor, pain management strategies should be
addressed. If her concern is about future pelvic floor disorders, her
health care provider should discuss labor and delivery management to
minimize these risks as well as a summary of the relevant scientific data.
In every case, discussions should maximize her understanding of the issues
and should be specific to her personal needs, such as future reproductive
plans, medical risk factors, psychologic needs, social and family
situation, and other factors. Risks and benefits of cesarean delivery on
maternal request versus planned vaginal delivery must be individualized
and based on a shared decisionmaking process. After thorough discussion
and review, cesarean delivery on maternal request may be a reasonable
alternative to planned vaginal delivery. When a health care provider
cannot support this request, it is appropriate to refer the woman to
another health care provider.
Birth is inherently a natural process. Most women would like to achieve
a spontaneous vaginal delivery and should be supported in their efforts to
achieve that goal. The available evidence and data comparing risks and
benefits of planned vaginal delivery and cesarean delivery on maternal
request are sparse and provide few clear conclusions. There is no direct
evidence comparing cesarean delivery on maternal request to planned
vaginal delivery. Because most studies attempting to make a valid
comparison fail to adjust for important confounders, inferences about
factors that can influence the harms and benefits must be interpreted
cautiously. Indirect evidence suggests relatively similar degrees of risk
from both pathways in women intending to limit their childbearing to one
or two children. Although the ratio of risks and benefits may be similar
on a population level, it will vary from woman to woman. Health care
providers should consider societal and cultural norms, the environment,
and physical resources, as well as individual patient factors. Each woman
deserves individualized counseling consistent with ethical principles and
based on the available scientific data when discussing the risk/benefit
ratio and the option of cesarean delivery on maternal request.
Back
to Top
4. What future research directions need to be considered to get
evidence for making appropriate decisions regarding cesarean delivery on
request or attempted vaginal delivery?
- Surveys of women (before and after birth), providers, insurers, and
healthcare facilities regarding cesarean delivery on maternal request
will provide a basis for assessing the current extent of cesarean
delivery on maternal request and attitudes about it.
- Mechanisms should be created to identify cesarean delivery on
maternal request, such as establishing Current Procedural Terminology
(CPT) coding and improving the birth certificate. This will facilitate
tracking and further research on short- and long-term risks and benefits
for mothers and children.
- There should be increased research devoted to strategies to predict
and influence the likelihood of successful vaginal birth, particularly
in the first pregnancy.
- Large multi-center, multi-disciplinary prospective cohort studies
enrolling participants early in the first pregnancy and following
mothers and children long-term are necessary to develop information
about the relative benefits and risks of planned vaginal versus planned
cesarean delivery.
- For rare but critical outcomes, very large databases will be the
only immediately available realistic source of reliable prospective
data. Such databases can be explored to assess incidence rates of a
variety of outcomes. Well-designed case–control studies also may be
helpful.
- The feasibility of randomized trials should be explored. It may be
difficult to enroll an adequate number of women willing to be randomized
to a planned cesarean delivery versus planned vaginal delivery.
- Future studies should determine whether there are modifiable factors
in the management of labor that can decrease maternal and neonatal
complications. Furthermore, an attempt should be made to identify
subgroups of women at higher risk for complications who would benefit
most from planned cesarean delivery on maternal request.
- Studies comparing cesarean delivery on maternal request and planned
vaginal delivery should consider the following key outcomes:
- Maternal
- Maternal death
- Placental abnormalities including previa and accreta
- Pelvic floor disorders (identification of birth-induced injuries
responsible for pelvic floor disorders later in life; effects of
pregnancy, labor, and delivery on continence and support mechanisms
while controlling for effects of aging on pelvic floor;
identification of modifiable factors in the management of labor that
would decrease risk of future pelvic floor disorders without having
to perform cesarean delivery; identifying a population at high risk
for development of pelvic floor disorders who would benefit most
from cesarean delivery on maternal request)
- Psychologic factors, including quality-of-life issues and
satisfaction with birth experience
- Neonatal
- Neonatal death
- Respiratory outcomes
- Neonatal encephalopathy, cerebral palsy, and other
neurodevelopmental outcomes
- Brachial plexus injury and other birth injuries
- A thorough assessment of the costs of cesarean delivery on maternal
request is warranted. These cannot be simply extrapolated from current
costs associated with cesarean delivery overall, which includes
expensive emergent procedures. Planned cesarean delivery on maternal
request will have different cost implications that should be modeled
explicitly.
Conclusions
- The incidence of cesarean delivery without medical or obstetric
indications is increasing in the United States, and a component of this
increase is cesarean delivery on maternal request. Given the tools
available, the magnitude of this component is difficult to quantify.
- There is insufficient evidence to evaluate fully the benefits and
risks of cesarean delivery on maternal request as compared to planned
vaginal delivery, and more research is needed.
- Until quality evidence becomes available, any decision to perform a
cesarean delivery on maternal request should be carefully individualized
and consistent with ethical principles.
- Given that the risks of placenta previa and accreta rise with each
cesarean delivery, cesarean delivery on maternal request is not
recommended for women desiring several children.
- Cesarean delivery on maternal request should not be performed prior
to 39 weeks of gestation or without verification of lung maturity,
because of the significant danger of neonatal respiratory complications.
- Maternal request for cesarean delivery should not be motivated by
unavailability of effective pain management. Efforts must be made to
assure availability of pain management services for all women.
- NIH or another appropriate Federal agency should establish and
maintain a Web site to provide up-to-date information on the benefits
and risks of all modes of delivery.
Back
to Top
State-of-the-Science Panel
Mary E. D’Alton, M.D. Panel and Conference
Chairperson Willard C. Rappleye Professor of Obstetrics and
Gynecology Chair, Department of Obstetrics and
Gynecology Director, Obstetrics and Gynecology Services, Columbia
University Medical Center College of Physicians and
Surgeons Columbia University New York, New York
Michael P. Aronson, M.D. Professor of
Obstetrics and Gynecology University of Massachusetts Medical
School Director of Women’s Health Services University of
Massachusetts Memorial Medical Center Worcester,
Massachusetts
David J. Birnbach, M.D. Professor and
Executive Vice Chairman, Department of Anesthesiology Chief,
Women’s Anesthesia, Jackson Memorial Hospital Director,
University of Miami Jackson Memorial Hospital Center for Patient
Safety Miller School of Medicine University of Miami Miami,
Florida
Michael B. Bracken, Ph.D., M.P.H., FACE Susan
Dwight Bliss Professor of Epidemiology Professor of Obstetrics,
Gynecology, Reproductive Science, and Neurology Center for
Perinatal, Pediatric and Environmental Epidemiology Yale
University New Haven, Connecticut
M. Yusoff Dawood, M.D. Professor of
Obstetrics and Gynecology Professor of Physiology Sanger Chair
in Family Planning and Reproductive Physiology West Virginia
University School of Medicine Health Sciences
Center Morgantown, West Virginia
William G. Henderson, Ph.D., M.P.H. Professor
and Biostatistics Core Director University of Colorado Health
Outcomes Program Professor, Department of Preventive Medicine and
Biometrics University of Colorado Aurora, Colorado
Barbara Hughes, C.N.M., M.S., M.B.A.,
FACNM Director of Nurse-Midwifery Exempla Saint
Joseph Hospital Clinical Faculty University of Colorado Health
Sciences Center Denver, Colorado
Alan H. Jobe, M.D., Ph.D. Professor of
Pediatrics University of Cincinnati Division of Pulmonary
Biology Cincinnati Children’s Hospital Medical
Center Cincinnati, Ohio
Vern L. Katz, M.D. Clinical Professor of
Obstetrics and Gynecology Oregon Health Science
University Adjunct Professor Department
Physiology University of Oregon Medical Director of Perinatal
Services Department of Obstetrics and Gynecology Sacred Heart
Medical Center Eugene, Oregon
Stephen R. Kraus, M.D., FACS Assistant
Professor and Deputy Chairman Department of Urology University
of Texas Health Science Center at San Antonio San Antonio, Texas
Meg Mangin, R.N. Dunn County Home Health
Care Menomonie, Wisconsin
JoAnn Elizabeth Matory, M.D. Clinical
Associate Professor of Pediatrics Department of
Pediatrics Indiana School of Medicine James Whitcomb Riley
Hospital for Children Indianapolis, Indiana
Thomas R. Moore, M.D. Professor and Chairman,
Department of Reproductive Medicine School of
Medicine University of California, San Diego Medical
Center San Diego, California
Patricia J. O’Campo, Ph.D. Professor, Public
Health Sciences University of Toronto Alma and Baxter Ricard
Chair in Inner City Health Director, Inner City Health Research
Unit St. Michael’s Hospital Toronto, Canada
Jeffrey F. Peipert, M.D., M.P.H., M.H.A. Vice
Chair of Clinical Research Professor Department of Obstetrics
and Gynecology Washington University in St. Louis School of
Medicine St. Louis, Missouri
Karen H. Rothenberg, J.D., M.P.A. Dean and
Marjorie Cook Professor of Law University of Maryland School of
Law Baltimore, Maryland
Meir Jonathan Stampfer, M.D.,
Dr.P.H. Professor of Medicine Professor of
Epidemiology and Nutrition Chair, Department of
Epidemiology Harvard School of Public Health Boston,
Massachusetts
Kimberly A. Yonkers, M.D. Associate
Professor Department of Psychiatry Department of Epidemiology
and Public Health Yale School of Medicine New Haven,
Connecticut
Back
to Top
Speakers
Susan Dentzer Health Correspondent and Head
of the Health Policy Unit The NewsHour with Jim Lehrer on
PBS Arlington, Virginia
Maurice L. Druzin, M.D. Professor and
Chief Division of Maternal-Fetal Medicine Obstetrics and
Gynecology Stanford University Stanford, California
Dee Fenner, M.D. Director of
Gynecology Department of Obstetrics and Gynecology University
of Michigan Ann Arbor, Michigan
Melissa L. Gilliam, M.D., M.P.H. Associate
Professor of Obstetrics, Gynecology, and Epidemiology The
University of Chicago Chicago, Illinois
Victoria L. Handa, M.D. Associate
Professor Department of Obstetrics and Gynecology Johns
Hopkins University Baltimore, Maryland
Gary D.V. Hankins, M.D. Professor and Vice
Chairman Department of Obstetrics and Gynecology University of
Texas Medical Branch at Galveston Galveston, Texas
Lucky Jain, M.D., M.B.A. Professor and
Executive Vice Chair Department of Pediatrics Emory
University Atlanta, Georgia
Mark A. Klebanoff, M.D.,
M.P.H. Director Division of Epidemiology, Statistics,
and Prevention Research National Institute of Child Health and
Human Development National Institutes of Health Bethesda,
Maryland
Fay Menacker, Dr.P.H.,
C.P.N.P. Statistician Division of Vital
Statistics National Center for Health Statistics Centers for
Disease Control and Prevention Hyattsville, Maryland
Howard Minkoff, M.D. Chairman Department
of Obstetrics and Gynecology Maimonides Medical
Center Brooklyn, New York
Millie Sullivan Nelson,
M.D. Head Department of Obstetrics and
Gynecology Christie Clinic at Champaign Champaign, Illinois
Ingrid Nygaard, M.D.,
M.S. Professor Department of Obstetrics and
Gynecology University of Utah College of Medicine Salt Lake
City, Utah
Holly E. Richter, Ph.D., M.D. Medical
Surgical Gynecology University of Alabama at
Birmingham Birmingham, Alabama
Benjamin P. Sachs, M.D. Professor and
Chair Obstetrics and Gynecology Beth Israel Deaconess Medical
Center Harvard Medical School Professor Department of
Obstetrics and Gynecology Harvard School of Public
Health Boston, Massachusetts
Anthony G. Visco, M.D. Associate
Professor Division of Urogynecology and Reconstructive Pelvic
Surgery Department of Obstetrics and Gynecology University of
North Carolina at Chapel Hill Chapel Hill, North Carolina
Meera Viswanathan, Ph.D. Research Health
Analyst RTI International Research Triangle Park, North
Carolina
Joseph R. Wax, M.D. Professor of Obstetrics
and Gynecology University of Vermont Maine Medical
Center Portland, Maine
Anne M. Weber, M.D., M.S. Program
Officer Contraception and Reproductive Health Branch National
Institute of Child Health and Human Development National
Institutes of Health Bethesda, Maryland
Back
to Top
Planning Committee
Catherine Y. Spong, M.D. Planning Committee
Chairperson Chief Pregnancy and Perinatology Branch National
Institute of Child Health and Human Development National
Institutes of Health Bethesda, Maryland
Duane Alexander, M.D. Director National
Institute of Child Health and Human Development National
Institutes of Health Bethesda, Maryland
David Atkins, M.D., M.P.H. Chief Medical
Officer Center for Practice and Technology Assessment Agency
for Healthcare Research and Quality Rockville, Maryland
Mary E. D’Alton, M.D. Panel and Conference
Chairperson Willard C. Rappleye Professor of Obstetrics and
Gynecology Chair, Department of Obstetrics and
Gynecology Director, Obstetrics and Gynecology
Services College of Physicians and Surgeons Columbia
University New York, New York
Kenneth Fink, M.D., M.G.A.,
M.P.H. Director Evidence-based Practice Centers
Program Center for Outcomes and Evidence Agency for Healthcare
Research and Quality Rockville, Maryland
Loretta P. Finnegan, M.D. Medical Advisor to
the Director Office of Research on Women’s Health National
Institutes of Health Bethesda, Maryland
Frank A. Hamilton, M.D.,
M.P.H. Chief Digestive Diseases Program Division
of Digestive Diseases and Nutrition National Institute of
Diabetes and Digestive and Kidney Diseases National Institutes of
Health Bethesda, Maryland
Victoria L. Handa, M.D. Associate
Professor Department of Obstetrics and Gynecology Johns
Hopkins University Baltimore, Maryland
Gary D.V. Hankins, M.D. Professor and Vice
Chairman Department of Obstetrics and Gynecology University of
Texas Medical Branch at Galveston Galveston, Texas
Barnett S. Kramer, M.D.,
M.P.H. Director Office of Medical Applications of
Research Office of the Director National Institutes of
Health Bethesda, Maryland
Kelli K. Marciel, M.A. Communications
Director Office of Medical Applications of Research Office of
the Director National Institutes of Health Bethesda,
Maryland
Susan Meikle, M.D., M.S.P.H. Medical
Officer Center for Outcomes and Evidence Agency for Healthcare
Research and Quality Rockville, Maryland
Howard Minkoff, M.D. Chairman Department
of Obstetrics and Gynecology Maimonides Medical
Center Brooklyn, New York
Lata S. Nerurkar, Ph.D. Senior Advisor for
Consensus Development Program Office of Medical Applications of
Research Office of the Director National Institutes of
Health Bethesda, Maryland
Nancy J. Norton President International
Foundation for Functional Gastrointestinal Disorders Milwaukee,
Wisconsin
Ingrid Nygaard, M.D.,
M.S. Professor Department of Obstetrics and
Gynecology University of Utah College of Medicine Salt Lake
City, Utah
William Oh, M.D. Professor of
Pediatrics Brown Medical School Attending
Neonatologist Women and Infants Hospital Providence, Rhode
Island
Vivian W. Pinn, M.D. Associate Director for
Research on Women’s Health Director Office of Research on
Women’s Health National Institutes of Health Bethesda,
Maryland
Tonse N.K. Raju, M.D. Medical Officer and
Program Scientist Pregnancy and Perinatology Branch Center for
Developmental Biology and Perinatal Medicine National Institute
of Child Health and Human Development National Institutes of
Health Bethesda, Maryland
Uma M. Reddy, M.D., M.P.H. Medical
Officer Pregnancy and Perinatology Branch National Institute
of Child Health and Human Development National Institutes of
Health Rockville, Maryland
Holly E. Richter, Ph.D., M.D. Medical
Surgical Gynecology University of Alabama at
Birmingham Birmingham, Alabama
Susan Rossi, Ph.D., M.P.H. Deputy
Director Office of Medical Applications of Research Office of
the Director National Institutes of Health Bethesda, Maryland
Mona Jaffe Rowe, M.C.P. Associate
Director Office of Science Policy, Analysis, and
Communications National Institute of Child Health and Human
Development National Institutes of Health Bethesda,
Maryland
Benjamin P. Sachs, M.D. Professor and
Chair Obstetrics and Gynecology Beth Israel Deaconess Medical
Center Harvard Medical School Professor Department of
Obstetrics and Gynecology Harvard School of Public
Health Boston, Massachusetts
James R. Scott, M.D. Editor Obstetrics and
Gynecology Department of Obstetrics and Gynecology University
of Utah Salt Lake City, Utah
Laura Toso, M.D. Postdoctoral Fellow Unit
on Perinatal and Developmental Neurobiology National Institute of
Child Health and Human Development National Institutes of
Health Bethesda, Maryland
Anne M. Weber, M.D., M.S. Program
Officer Contraception and Reproductive Health Branch National
Institute of Child Health and Human Development National
Institutes of Health Bethesda, Maryland
Conference Sponsors
National Institute of Child Health and Human
Development Duane Alexander, M.D. Director
Office of Medical Applications of
Research Barnett S. Kramer, M.D., M.P.H. Director
Conference Cosponsors
National Institute of Diabetes and Digestive and Kidney
Diseases Allen M. Spiegel, M.D. Director
National Institute of Nursing
Research Patricia A. Grady, Ph.D., R.N.,
FAAN Director
Office of Research on Women’s Health Vivian
W. Pinn, M.D. Director
Back
to Top | |